Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 9, 2004, Pages 1346-1348

  Kleiter, I ^a   Hans, V H ^b   Schuierer, G ^a   Marienhagen, J ^a   Hau, P ^a   Schutz H ^c   Bogdahn, U ^a   Steinbrecher, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Eye Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AZATHIOPRINE; CEFOTAXIME; CYTARABINE; TRIAMCINOLONE ACETONIDE;

ADULT; ANAMNESIS; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CASE REPORT; CELL INFILTRATION; CELL STIMULATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MENINGITIS; MONONUCLEAR CELL; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT FAILURE; VISUAL ACUITY;

ADULT; CHRONIC DISEASE; CYTARABINE; DISEASE PROGRESSION; DURA MATER; HEADACHE; HUMANS; HYPERTROPHY; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; MALE; MENINGITIS; TREATMENT OUTCOME;

EID: 4344617915     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.024653     Document Type: Article

References (12)

1. Masson C, Henin D, Hauw JJ, et al. Cranial pachymeningitis of unknown origin: a study of seven cases. Neurology 1993;43:1329-34.
2. Dumont AS, Clark AW, Sevick RJ, et al. Idiopathic hypertrophic pachymeningitis: a report of two patients and review of the literature. Can J Neurol Sci 2000;27:333-40.
3. Voller B, Vass K, Wanschitz J, et al. Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region. Neurology 2001;56:107-9.
4. Hatano N, Behari S, Nagatani T, et al. Idiopothic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options. Neurosurgery 1999;45:1336-42; discussion 42-4.
5. Choi IS, Park SC, Jung YK, et al. Combined therapy of corticosteroid and azathioprine in hypertrophic cranial pachymeningitis. Eur Neurol 2000;44:193-8.
6. Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994;122:189-203.
7. Yamaki T, Ikeda T, Sakamoto Y, et al. Lymphoplasmacyte-rich meningioma with clinical resemblance to inflammatory pseudotumor. Report of two cases. J Neurosurg 1997;86:898-904.
8. Pittella JE, da Costa CC, Giannetti AV, et al. October 2000: a 47 year old man with long-standing progressive tetraparesis. Brain Pathol 2001;11:261-2.
9. Bohuslavirki KH. Somatostatin receptor imaging: current status and future perspectives. J Nucl Med 2001;42:1057-8.
10. Berger JR, Snodgrass S, Glaser J, et al. Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis. Neurology 1989;39:1345-9.
11. Wouda EJ, Vanneste JA. Aspecific headache during 13 years as the only symptom of idiopathic hypertrophic pachymeningitis. J Neurol Neurosurg Psychiatry 1998;64:408-9.
12. Yamamoto T, Goto K, Suzuki A, et al. Long-term improvement of idiopathic hypertrophic cranial pachymeningitis by lymphocytapheresis. Ther Apher 2000;4:313-16.